Mimetas
Series BMimetas raised €16M in a Series B round in Feb 2018. The company is based in Leiden, Netherlands. Investors in the round: Aglaia Oncology Fund II, Cathay Capital, European Life Sciences Growth Fund and 3 others. Data as of 4 Nov 2026.
Amount raised
€16M
€16,456,611
Native amount
20,500,000 USD
Stage
Series B
series b
Investors
6
Provenance & confidence
High confidenceAmount
20,500,000 USD
ECB-at-date → €16M · rate 1.2457 on 2018-01-31
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
6 namedAglaia Oncology Fund IICathay CapitalEuropean Life Sciences Growth FundInnovationQuarterKorysOost NL
Date
Feb 2018
Round type
series b
Amount (EUR)
€16M